scispace - formally typeset
M

Manuel Carnero-Alcázar

Researcher at Hospital Clínico San Carlos

Publications -  57
Citations -  335

Manuel Carnero-Alcázar is an academic researcher from Hospital Clínico San Carlos. The author has contributed to research in topics: Medicine & Aortic valve replacement. The author has an hindex of 10, co-authored 38 publications receiving 292 citations.

Papers
More filters
Journal ArticleDOI

Validation of EuroSCORE II on a single-centre 3800 patient cohort

TL;DR: EuroSCORE II demonstrated good discriminative capacity and poor calibration in the patients undergoing major cardiac surgery at the centre and both scales showed a good discrim inative capacity for all the pathologies subgroups.
Journal ArticleDOI

Short- and mid-term results for aortic valve replacement in octogenarians

TL;DR: It is concluded that conventional open AVR for degenerative aortic stenosis grants good early- and mid-term outcomes in octogenarians in the experience.
Journal ArticleDOI

Transapical aortic valve prosthetic endocarditis.

TL;DR: An 83-year-old patient who underwent a transapical aortic valve implantation and was readmitted to her institution because of fever and heart failure died shortly after the diagnosis of prosthetic aortsic valve endocarditis.
Journal ArticleDOI

Transcatheter versus surgical aortic valve replacement in moderate and high-risk patients: a meta-analysis.

TL;DR: TAVR and SAVR have similar short and long-term all-cause mortality and risk of stroke among patients of moderate or high surgical risk and TAVR decreases the risk of major bleeding, acute kidney injury and improves haemodynamic performance compared with S AVR but increases the risk with vascular complications, the need for a pacemaker and residual aortic regurgitation.
Journal ArticleDOI

SYNTAX Score is associated with worse outcomes after off-pump coronary artery bypass grafting surgery for three-vessel or left main complex coronary disease

TL;DR: In this subset of patients, a higher SYNTAX Score was associated with a higher incidence of in-hospital and follow-up major adverse cardiac and cerebrovascular events after coronary artery bypass grafting, but not with early or late mortality.